Posted on 10/21/20
| News Source: MATZAV
None of the trials of COVId-19 candidate vaccines can detect a reduction in serious outcomes such as hospitalization or death, a leading public health expert said Thursday.
Writing in the BMJ medical journal, associate editor Peter Doshi warned that not even phase 3 trials under way in the race for a vaccine can prove their product will prevent people contracting COVID-19.
Join BJL status for engagements, births, deals, levayos, events & more: https://bit.ly/32HUBnJ
Join an official BJL WhatsApp group for breaking news as it happens: https://bit.ly/3aYxo4v
In a sobering essay, Doshi said those hoping for a breakthrough to end the pandemic would be disappointed, with some vaccines likely to reduce the risk of infection by only 30 percent.
Read more at NEWSMAX.